The ambiguity of these data led us to investigate mifamurtide efficacy on three OS cell lines, characterized by a different degree of malignancy, through in vitro experiments after co-culturing the tumor cells with CD14+ cells (monocytes). Here, CD14 is linked to neoplasm.